HECATOS. HEPATIC AND CARDIAC TOXICITY SYSTEMS MODELLING.
Datos básicos
- Protocolo:
- 602156_HECATOS_PE_FP7-HEALTH-2013-INNOVATI
- EUDRACT:
- NCT:
- Centro:
- Año de incio:
- 2013
- Año de finalización:
- 2018
Objetivos del proyecto
FAVORABLE
Documentos
- No hay documentos
Participantes
-
Hernán González King Garibotti
Licenciado
-
José Vicente Castell Ripoll
Investigador Principal
-
Pilar Sepúlveda Sanchis
Doctor
-
Silvia Sánchez Salvo
Colaborador/A
-
Isabel Conde Amiel
Licenciado
-
Ana Maria Cervera Zamora
Licenciado
-
Nahuel Aquiles Garcia
Doctor
-
María Ciria Calduch
Licenciado
-
Rafael Sánchez Sánchez
Licenciado
-
Sandra Tejedor Gascón
Licenciado
-
Akaitz Dorronsoro González
Doctor
-
Beatriz Ranera Beltran
Doctor
-
María Teresa Martínez Sena
Licenciado
-
Arturo López Castel
Doctor
-
Marta Gómez Ferrer
Licenciado
-
Giovanna Luongo
Licenciado
Grupos
-
Hepatología experimental y Trasplante hepático
Investigador Principal
Laia Tolosa Pardo
-
Unidad Mixta de Investigación en Hepatología Experimental
Investigador Principal
Ramiro Jover Atienza
Resultados del Ensayo Clínico
CELL SOURCES FOR HEPATIC CELL THERAPY
EUGENIA PAREJA IBARS, MARÍA JOSÉ GÓMEZ-LECHÓN MOLINER, LAIA TOLOSA PARDO
Capítulo de un Libro. 2017
CELL-BASED THERAPEUTIC STRATEGIES FOR TREATMENT OF LIVER DISEASES.
LAIA TOLOSA PARDO, MARÍA JOSÉ GÓMEZ-LECHÓN MOLINER, EUGENIA PAREJA IBARS
Capítulo de un Libro. 2017
Polymer Therapeutics as nano-sized medicines for Tissue Regeneration and Repair
Armiñán, Ana, PILAR SEPÚLVEDA SANCHIS, Vicent, María Jesús
Libro Completo. 2014
[Liver cell therapy in the treatment of inborn errors of metabolism in children].
Abstract of Published Item. 10.1016/j.anpedi.2013.05.018. 2013
Conductive polycaprolactone/gelatin/polyaniline nanofibres as functional scaffolds for cardiac tissue regeneration
Gil-Castell, O.; (...); Ribes-Greus, A.
Article. 10.1016/j.reactfunctpolym.2021.105064. 2022
2017 SEOM guidelines: a multidisciplinary approach
Santaballa, A, Vera, R
Editorial Material. 10.1007/s12094-018-1830-7. 2018
A Comparison of Electrospun Polymers Reveals Poly(3-Hydroxybutyrate) Fiber as a Superior Scaffold for Cardiac Repair
Castellano D; (...); Sepúlveda P
Article. 10.1089/scd.2013.0578. 2014
A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
de la Fuente, Ana; (...); Ravassa, Susana
Article. 10.3390/cancers14122941. 2022
A lipidomic cell-based assay for studying drug-induced phospholipidosis and steatosis
Garcia-Canaveras, JC; (...); Lahoz, A
Article. 10.1002/elps.201700079. 2017
A metabolomics cell-based approach for anticipating and investigating drug-induced liver injury
García-Cañaveras JC; (...); Lahoz A
Article. 10.1038/srep27239. 2016
A microRNA signature for valproate-induced steatosis in human hepatocytes and its application to predict fatty liver in paediatric epileptic patients on valproate therapy.
Soluyanova P; (...); Jover R
Article. 10.1016/j.tox.2024.153974. 2024
A multicentric single-arm phase II clinical trial to evaluate safety and efficacy of the combination of olaparib and PLD for platinum resistant ovarian primary peritoneal carcinoma and fallopian tube cancer patients: The GEICO-1601 ROLANDO trial-A trial in resistant ovarian cancer with olaparib and pegylated liposomal doxorubicin.
Perez-Fidalgo, JA; (...); Gonzalez-Martin, A
Meeting Abstract. 10.1200/JCO.2018.36.15_suppl.TPS5610. 2018
A Multi-Parametric Fluorescent Assay for the Screening and Mechanistic Study of Drug-Induced Steatosis in Liver Cells in Culture.
Tolosa, Laia, Gomez-Lechon, M Jose, Donato, M Teresa
Article. 10.1002/cptx.20. 2017
A novel microRNA signature for cholestatic drugs in human hepatocytes and its translation into novel circulating biomarkers for drug-induced liver injury patients.
López-Riera M; (...); Jover R
Article. 10.1093/toxsci/kfz138. 2020
A phase II proof-of-concept study of palbociclib (P) rechallenge in patients (pts) with hormone receptor (HR)[+]/HER2[-] metastatic breast cancer (MBC) and clinical benefit to prior P-based treatment (BIOPER)
Llombart-Cussac, A; (...); Albanell, J
Meeting Abstract. 2021
A randomized controlled clinical trial of cardiac telerehabilitation with a prolonged mobile care monitoring strategy after an acute coronary syndrome.
Dalli Peydro, Ernesto; (...); Cosin Sales, Juan
Article. 10.1002/clc.23757. 2022
A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study.
Gavilá J; (...); Llombart-Cussac A
Article. 10.1007/s12094-019-02145-4. 2020
A Score Model for the Continuous Assessment of Early Allograft Function after Liver Transplantation
Cortes, Miriam; (...); Lahoz, Agustin
Article. 2014
A Score Model for the Continuous Grading of Early Allograft Dysfunction Severity
Article. 10.1002/lt.23990. 2015
A Score Model for the Continuous Grading of Early Allograft Dysfunction Severity Reply
Hervás D, Lahoz A
Letter. 10.1002/lt.24408. 2016
A simple transcriptomic signature able to predict drug-induced hepatic steatosis
Article. 10.1007/s00204-014-1197-7. 2014
A small molecule G6PD inhibitor reveals immune dependence on pentose phosphate pathway.
Ghergurovich JM; (...); Rabinowitz JD
Article. 10.1038/s41589-020-0533-x. 2020
A Smart Digital Health Platform to Enable Monitoring of Quality of Life and Frailty in Older Patients with Cancer: A Mixed-Methods, Feasibility Study Protocol.
Papachristou, Nikolaos; (...); Bamidis, Panagiotis D.
Article. 10.1016/j.soncn.2023.151437. 2023
Activation of mesenchymal stem cells migration and spreading is mediated by crosslink of HIF, NOTCH and SUMO pathways
Ciria, M.; (...); Sepulveda, P.
Meeting Abstract. 2016
Adherence and adverse events of intraperitoneal chemotherapy in optimally debulked ovarian cancer patients: Real-life study.
Ballesta-López O; (...); Poveda-Andrés JL
Article. 10.1177/1078155220915953. 2020
Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems
Fernandez-Murga, ML; (...); Jover, R
Review. 10.1016/j.fct.2018.07.017. 2018
Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis
Article. 10.1016/j.taap.2016.04.007. 2016
ADVERSE EFFECTS OF TRIPLE THERAPY WITH BOCEPREVIR (BOC) AND TELAPREVIR (TVR) IN CLINICAL PRACTICE IN PATIENTS WITH ADVANCED HEPATIC FIBROSIS
Salmeron, J.; (...); Prieto, M.
Article. 10.1016/S0168-8278(14)61356-8. 2014
Albumin dialysis with MARS for the treatment of anabolic steroid-induced cholestasis
Diaz, FC; (...); Prieto, M
Article. 10.5604/16652681.1222114. 2016
Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting The MENTE Study
Rodríguez-Nóvoa S; (...); Castro Á
Article. 10.1097/MCG.0000000000000569. 2016
Altered underlying tubular function in HBV monoinfected patients receiving nucleos(t)ide analogs in a real-world setting: MENTE Study
Rodriguez Novoa, Sonia; (...); Castro, Angeles
Article. 2014
Alternative Cell Sources to Adult Hepatocytes for Hepatic Cell Therapy.
Pareja, E, Gomez-Lechon, MJ, Tolosa, L
Article. 10.1007/978-1-4939-6506-9_2. 2017
ANABOLIC ANDROGENIC STEROIDS (AAS) ILLICIT USE IS A RAPIDLY GROWING CAUSE OF DRUG-INDUCED LIVER INJURY (DILI): A PROSPECTIVE SERIES FROM THE SPANISH-LATIN-AMERICAN DILI REGISTRY
Medina-Caliz, I.; (...); Andrade, R. J.
Article. 10.1016/S0168-8278(14)60472-4. 2014
Analysis of Exosome Transfer in Mammalian Cells by Fluorescence Recovery after Photobleaching
Gonzalez-King, H; (...); Sepulveda, P
Article. 10.21769/BioProtoc.2692. 2018
ANALYSIS OF THE CLINICAL EXPERIENCE WITHIN RUCAPARIB'S EARLY ACCESS PROGRAM IN SPAIN - A GEICO STUDY
Yubero-Esteban, A.; (...); Gonzalez-Martin, A.
Meeting Abstract. 10.1136/ijgc-2021-ESGO.398. 2021
Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study).
Tavira B; (...); González-Martín A
Article. 10.1158/1078-0432.CCR-23-0771. 2024
Aneurisma del ductus arterioso: diagnóstico prenatal y evolución.
ESTEBAN PEIRÓ MOLINA, ANTONIO SANCHEZ ANDRES, JOSÉ IGNACIO CARRASCO MORENO
Article. DOI: 10.1016/j.anpedi.2016.10.007. 2017
Angiopoietin-like protein 8 is a novel vitamin D receptor-targeted lipogenic gene associated with non-alcoholic fatty liver
Gonzalez-Rodriguez, A; (...); Garcia-Monzon, C
Meeting Abstract. 10.1016/S0168-8278(18)30948-6. 2018
Anthracycline mediated cardiotoxicity: Detection of miRNA based early biomarkers for the prediction of myocardial injury. Hecatos study
Coloma, C. Salvador; (...); Santaballa, A.
Meeting Abstract. 10.1093/annonc/mdw365.69. 2016
Aortic arch dilation in bicuspid aortic valve disease: Predictive factors and medium-term follow-up
Berbel, A; (...); Montero, JA
Article. 10.1016/j.circv.2016.11.056. 2017
Apicobasal Polarity Controls Lymphocyte Adhesion to Hepatic Epithelial Cells
Reglero-Real N; (...); Millán J
Article. 10.1016/j.celrep.2014.08.007. 2014
Arterial embolization of polycystic kidneys as current alternative to nephrectomy before kidney transplant
Palomo, FG; (...); Rico, EB
Meeting Abstract. 2021
Assessing ATR-FTIR spectroscopy for steatosis quantification in liver biopsies in a long-duration cross-sectional study
Rienda, Ivan; (...); Quintas, Guillermo
Article. 10.1016/j.microc.2024.110135. 2024
Assessment of the cytotoxic potential of an aqueous-ethanolic extract from Thalassia testudinum angiosperm marine grown in the Caribbean Sea.
Rodeiro, I; (...); Lopes, M
Article. 10.1111/jphp.13001. 2018
Association of Cardiac Abnormalities to the Frail Phenotype in Cirrhotic Patients on the Waitlist: From the Functional Assessment in Liver Transplantation Study
Puchades, L; (...); Lai, JC
Article. 10.1097/TP.0000000000002025. 2018
Atezolizumab (atezo) combined with platinum-based chemotherapy (CT) and maintenance niraparib for recurrent ovarian cancer (rOC) with a platinum-free interval (TFIp) >6 months: Primary analysis of the double-blind placebo (pbo)controlled ENGOT-Ov41/GEICO 69-O/ANITA phase III trial
Martin, A. Gonzalez; (...); Selle, F.
Meeting Abstract. 10.1016/j.annonc.2023.10.031. 2023
Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial.
Gonzalez-Martin, Antonio; (...); Selle, Frederic
Article. 10.1200/JCO.24.00668. 2024
ATR-FTIR spectroscopy for the routine quality control of exosome isolations
Ramos-Garcia, V; (...); Kuligowski, J
Article. 10.1016/j.chemolab.2021.104401. 2021
Atypical presentation of a giant atrial myxoma
Dominguez-Massa, C, Bel-Minguez, AM, Montero-Argudo, JA
Article. 10.1016/j.circv.2017.07.003. 2018
Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen alleles
Stephens, C; (...); Lucena, MI
Article. 10.1097/FPC.0000000000000230. 2016
Balance of Active, Passive, and Anatomical Cardiac Properties in Doxorubicin-Induced Heart Failure.
Lewalle A; (...); Niederer SA
Article. 10.1016/j.bpj.2019.07.033. 2019
Baseline circulating myeloid-derived suppressor cells correlate with neutrophil-to-lymphocyte ratio and overall survival in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors
Garcia-Sanchez, J.; (...); Lahoz, A.
Meeting Abstract. 2021
Baseline circulating myeloid-derived suppressor cells subpopulations, neutrophils/lymphocytes ratio, and response to PD-1/PD-L1 inhibitor in non-small cell lung cancer patients.
SAnchez, JosE GarcIa; (...); Lahoz, Agustin
Meeting Abstract. 2020
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial
Hochman, JS; (...); ISCHEMIA Res Grp
Article. 10.1001/jamacardio.2019.0014. 2019
Baseline features of hepatitis C patients associated to prescription of pangenotypic antiviral treatments: results from the real-world Spanish Hepa-C registry
Turnes, Juan; (...); Perez Cachafeiro, Santiago
Meeting Abstract. 2020
Beneficial effects of hepatic cyclooxygenase-2 expression against cholestatic injury after common bile duct ligation in mice.
Brea, Rocio; (...); Frances, Daniel E
Article. 10.1111/liv.16004. 2024
Bladder cancer recurrence surveillance by urine metabolomics analysis
Loras, A; (...); Ruiz-Cerda, JL
Article. 10.1038/s41598-018-27538-3. 2018
Both cholestatic and steatotic drugs trigger extensive alterations in the mRNA level of biliary transporters in rat hepatocytes: Application to develop new predictive biomarkers for early drug development
Article. 10.1016/j.toxlet.2016.10.008. 2016
Brain abscesses in early post-liver transplantation.
Mínguez Sabater A; (...); Prieto Castillo M
Case Reports. 10.1016/j.eimc.2021.02.002. 2021
Brain abscesses in early post-liver transplantation.
Minguez Sabater, Alejandro; (...); Prieto Castillo, Martin
Article. 10.1016/j.eimce.2021.09.007. 2021
Calorie restriction improves metabolic state independently of gut microbiome composition: a randomized dietary intervention trial.
Sowah, Solomon A.; (...); Zeller, Georg
Article. 10.1186/s13073-022-01030-0. 2022
Cardiomyocyte exosomes regulate glycolytic flux in endothelium by direct transfer of GLUT transporters and glycolytic enzymes
Garcia NA; (...); Diez-Juan A
Article. 10.1093/cvr/cvv260. 2016
Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations.
López-Fernández T; (...); López Sendón Henchel JL
Article. 10.1016/j.rec.2016.12.041. 2017
Cardiopulmonary Rehabilitation Improves Respiratory Muscle Function and Functional Capacity in Children with Congenital Heart Disease. A Prospective Cohort Study
Ferrer-Sargues FJ; (...); Iranzo, MACI
Article. 10.3390/ijerph17124328. 2020
Causes of Cardiovascular and Non-Cardiovascular Death in the ISCHEMIA Trial.
Sidhu, Mandeep S.; (...); ISCHEMIA Research Group
Article. 10.1016/j.ahj.2022.01.017. 2022
CFD analysis of the HVAD's hemodynamic performance and blood damage with insight into gap clearance
Gil A; (...); Montero JA
Article. 10.1007/s10237-022-01585-2. 2022
cGMP-Phosphodiesterase Inhibition Prevents Hypoxia-Induced Cell Death Activation in Porcine Retinal Explants
Olivares-González L; (...); Rodrigo R
Article. 10.1371/journal.pone.0166717. 2016
Circulating exosomes deliver free fatty acids from the bloodstream to cardiac cells: Possible role of CD36
Garcia, NA; (...); Sepulveda, P
Article. 10.1371/journal.pone.0217546. 2019
Clinical and molecular signature of survival and resistance to olaparib plus pegylated liposomal doxorubicin in platinum-resistant ovarian cancer: a stratified analysis from the phase II clinical trial ROLANDO, GEICO-1601.
Perez-Fidalgo, Jose Alejandro; (...); Gonzalez-Martin, Antonio
Article. 10.1136/ijgc-2022-004028. 2023
Clinical Application of Pluripotent Stem Cells: An Alternative Cell-Based Therapy for Treating Liver Diseases?
Tolosa L, Pareja E, Gomez-Lechon MJ
Review. 10.1097/TP.0000000000001426. 2016
Clinical characteristics and outcomes of elderly included in the Spanish Drug-Induced Liver Injury (DILI) Registry
Slim, M; (...); Andrade, RJ
Meeting Abstract. 10.1016/S0168-8278(17)31154-6. 2017
Clinical experience with rucaparib after prior PARPi treatment: A subanalysis from the rucaparib access program in Spain by GEICO.
Yubero-Esteban, Alfonso; (...); Sanchez Lorenzo, Maria Luisa
Meeting Abstract. 2022
Clinical features and risk factors associated with Non-alcoholic steatohepatitis (NASH) in Spain. On behalf of HEPAmet Registry
Gallego-Duran, Rocio; (...); Romero-Gomez, Manuel
Article. 2015
Clinical insights from the rucaparib access program in Spain: A sub-analysis of long-term responders by GEICO.
Yubero-Esteban, Alfonso; (...); Gonzalez Martin, Antonio
Meeting Abstract. 2022
Clinical outcomes of patients delisted from thewaiting list of liver transplantation after interferon-free antiviral therapy
Pascasio, JM; (...); Londono, MC
Meeting Abstract. 10.1016/S0168-8278(17)30661-X. 2017
Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation
Pascasio, JM; (...); Londoño MC
Article. 10.1016/j.jhep.2017.08.008. 2017
CLINICAL PRESENTATION AND OUTCOMES OF DE NOVO HEPATITIS B VIRUS INFECTION AFTER LIVER TRANSPLANTATION IN SPAIN.
Pascasio Acevedo, Juan Manuel; (...); Manuel Sousa, Jose
Meeting Abstract. 2019
c-MYC Triggers Lipid Remodelling During Early Somatic Cell Reprogramming to Pluripotency
Prieto, Javier; (...); Torres, Josema
Article. 10.1007/s12015-021-10239-2. 2021
Co-administration of human MSC overexpressing HIF-1a increases human CD34(+) cell engraftment in vivo.
Preciado S; (...); Sánchez-Guijo F
Article. 10.1186/s13287-021-02669-z. 2021
Comparing the direct assessment of steatosis in liver explants with mid- and near-infrared vibrational spectroscopy, prior to organ transplantation.
Rienda, Ivan; (...); Quintas, Guillermo
Article. 10.1039/d3an01184d. 2023
Competency of different cell models to predict human hepatotoxic drugs
Gómez-Lechón MJ; (...); Donato MT
Review. 10.1517/17425255.2014.967680. 2014
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI registry.
Stephens C; (...); Andrade RJ
Article. 10.1016/j.jhep.2021.01.029. 2021
Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020).
Rodríguez M; (...); García-Samaniego J
Article. 10.1016/j.gastrohep.2020.03.011. 2020
Control of Diabetes Mellitus in Liver Transplant Recipients
Ramos-Prol, Agustin; (...); Francisco Merino-Torres, Juan
Article. 2014
Corrigendum to "Plasmatic Membrane Expression of Adhesion Molecules in Human Cardiac Progenitor/Stem Cells Might Explain Their Superior Cell Engraftment after Cell Transplantation".
Ontoria-Oviedo I; (...); Sepúlveda P
Correction. 10.1155/2022/9786160. 2022
Culture and Functional Characterization of Human Hepatoma HepG2 Cells.
Donato, MT, Tolosa, L, Gomez-Lechon, MJ
Article. 10.1007/978-1-4939-2074-7_5. 2015
Current status and future perspectives of hepatocyte transplantation
Review. 10.1016/j.ciresp.2013.04.010. 2014
Current Status of Cardio-Oncology in Spain: A National Multidisciplinary Survey.
Martín-García A; (...); López-Fernández T
Letter. 10.1016/j.rec.2017.11.002. 2019
Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury
Tolosa, L; (...); Teresa Donato, M.
Article. 10.1007/s00204-017-2036-4. 2018
CXCR7 reactivates ERK signaling to promote resistance to EGFR kinase inhibitors in NSCLC.
Becker JH; (...); Shimamura T
Article. 10.1158/0008-5472.CAN-19-0024. 2019
Cyclin E cytoplasmatic isoform to predict outcome and benefit to capecitabine treatment in patients with HR+/HER2-metastatic breast cancer from the GEICAM/2013-02 PEARL study
Guerrero, Angel; (...); Martin, Miguel
Meeting Abstract. 2023
Changes in human skin composition due to intrinsic aging: a histologic and morphometric study.
Arnal-Forne, Marta; (...); Ruiz-Sauri, Amparo
Article. 10.1007/s00418-024-02305-w. 2024
Changes in lipid metabolism driven by steroid signalling modulate proteostasis in C. elegans.
Gomez-Escribano, Ana P.; (...); Vazquez-Manrique, Rafael P.
Article. 10.15252/embr.202255556. 2023
Characterisation of iPSCs from a patient with transposition of the great arteries
Ontoria-Oviedo, I; (...); Sepulveda, P
Meeting Abstract. 2017
CHARACTERIZATION OF HBsAg LOSS IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH NUCLEOS/TIDE ANALOGS (NUCS): A RETROSPECTIVE MULTICENTER STUDY (HEBESAS)
Suarez, E.; (...); Fuentes, J.
Article. 10.1016/S0168-8278(15)30854-0. 2015
Characterization of hiPSC-CMs derived from pediatric cancer patients treated with anthracyclines that suffered cardiotoxicity
Reinal, I.; (...); Sepulveda, P.
Meeting Abstract. 2021
Characterization of Proliferating Human Hepatocytes As a Model System for Drug Interaction Studies and Toxicity Screenings
Noerenberg, A; (...); Jover, R
Meeting Abstract. 2017
Characterization of the gene expression profile of breast cancer tumours in patients undergoing ovarian stimulation for fertility preservation purposes
Soriano, M. J.; (...); Diaz-Garcia, C.
Meeting Abstract. 2022
Chemokine Receptor CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC
Becker, J; (...); Shimamura, T
Meeting Abstract. 10.1016/j.jtho.2019.08.1478. 2019
Chronological and Biological Age as a Response Factor to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
Suay, G.; (...); Juan-Vidal, O.
Meeting Abstract. 2024
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection
Fontana RJ; (...); Reddy KR
Article. 10.1002/lt.24416. 2016
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.
Chen Q; (...); Quer J
Article. 10.1016/j.antiviral.2019.104694. 2020
Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury
Medina-Caliz, I; (...); Spanish DILI Registry
Article. 10.1016/j.jhep.2016.05.003. 2016
Development of primary human NSCLC patient derived xenograft and organoids models as a precision approach to tumor treatment
Vidal, OJJ; (...); Farras, R
Meeting Abstract. 2018
Diagnostic power of echocardiographic speckle tracking of the tricuspid annular motion to assess right ventricular dysfunction
Alonso P; (...); Salvador A
Letter. 10.1016/j.ijcard.2013.12.157. 2014
Diagnostic preformance of mass spectometry metabolomics for assessment of early myocardial ischemia
Munoz, B. Igual; (...); Sepulveda-Sanchis, P. S. S.
Meeting Abstract. 2016
Differential Gene Expression of Cardiac Ion Channels in Human Dilated Cardiomyopathy
Micaela Molina-Navarro, Maria; (...); Rivera, Miguel
Article. 2013
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study (vol 18, pg 2513, 2018)
Manzardo, C.; (...); Samuel, D.
Article. 2018
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study (vol 18, pg 2513, 2018)
Manzardo, C.; (...); Samuel, D.
Correction. 10.1111/ajt.15244. 2019
Dissected aberrant right subclavian artery with Kommerell diverticulum.
Domínguez-Massa C; (...); Montero-Argudo JA
Article. 10.1016/j.repc.2017.07.023. 2019
Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids
Robles-Diaz M; (...); SLatinDILI Network
Article. 10.1111/apt.13023. 2015
DISTINGUISHING DRUG INDUCED AUTOIMMUNE HEPATITIS FROM IDIOPATIC AUTOIMMUNE HEPATITIS
Ortega-Alonso, A.; (...); Lucena, M. I.
Article. 10.1016/S0168-8278(15)31294-0. 2015
DRESS cases included in the Spanish and Latin-American DILI registries: clinical phenotype and outcome
Medina-Caliz, I; (...); Andrade, RJ
Meeting Abstract. 10.1016/S0168-8278(18)31459-4. 2018
Ductus arteriosus aneurysm: Prenatal diagnosis and outcome
Peiró Molina E, Sánchez Andrés A, Carrasco Moreno JI
Editorial Material. 10.1016/j.anpedi.2016.10.007. 2017
Early detection of chemotherapy-induced cardiotoxicity in breast cancer patients
Salvador-Coloma, C; (...); Santaballa, A
Meeting Abstract. 2018
Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study
De Simone, P; (...); Samuel, D
Article. 10.1097/TP.0000000000001171. 2016
Early radiological response as predictor of overall survival in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor mutations
Salvador-Coloma, C; (...); Juan, O
Article. 10.21037/jtd.2018.02.30. 2018
Economic evaluation of percutaneous cryoablation vs conventional surgery in extra-abdominal desmoid tumours in the Spanish healthcare system
Narvaez, Jose Antonio; (...); Ortiz-Cruz, Eduardo
Article. 10.1186/s13244-023-01580-w. 2024
Effectiveness and safety of ombitasvir, paritaprevir, ritonavir +/- dasabuvir +/- ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection
Perello, C; (...); Spanish Collaborative Group for the Study of the Use of Hepatitis C Direct-Actin
Article. 10.1111/jvh.12637. 2017
Effectiveness of 8 weeks of glecaprevir/pibrentasvir in treatment-naive hepatitis C patients with liver cirrhosis: results from the real-world Spanish Hepa-C registry
Turnes, Juan; (...); Perez Cachafeiro, Santiago
Meeting Abstract. 2020
Effectiveness of group therapy in women with localized breast cancer
Bellver-Perez, A, Peris-Juan, C, Santaballa-Beltran, A
Article. 10.1016/j.ijchp.2019.02.001. 2019
Effectiveness of ribavirin use associated with direct-acting antivirals in the treatment of non-cirrhotic patients with genotype 1a or 4 HCV infection in real-world practice
Ruiz-Antoran, B; (...); Panero, JLC
Meeting Abstract. 10.1016/S0168-8278(17)31448-4. 2017
EFFECTIVENESS OF TRIPLE THERAPY WITH BOCEPREVIR OR TELAPREVIR IN A MULTICENTRE CLINICAL PRACTICE COHORT OF HCV TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED HEPATIC FIBROSIS. SVR-12W AFTER TREATMENT
FERNANDEZ, C.; (...); Salmeron, J.
Article. 10.1016/S0168-8278(14)61360-X. 2014
Effectiveness, safety/tolerability of OBV/PTV/r +/- DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb/V and dialysis in Spanish clinical practice - preliminary data Vie-KinD study
Londono, MC; (...); De Alvaro, C
Meeting Abstract. 10.1016/S0168-8278(17)31920-7. 2017
Effects of Cardiopulmonary Rehabilitation on the Muscle Function of Children with Congenital Heart Disease: A Prospective Cohort Study.
Ferrer-Sargues FJ; (...); Salvador-Coloma P
Article. 10.3390/ijerph18115870. 2021
Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study
Salcedo, M; (...); Bañares R
Article. 10.1111/tri.12999. 2017
Efficacy and safety of glecaprevir/pibrentasvir for the pangenotypic treatment of chronic hepatitis C in former intravenous drug users: Subanalysis from a Spanish real-world cohort (Hepa-C)
Puigvehi, M; (...); Carrion, JA
Meeting Abstract. 10.1016/S0618-8278(19)30399-8. 2019
Efficacy and Safety of Therapy With Simeprevir and Sofosbuvir in Liver Transplant Recipients Infected by Hepatitis C Virus Genotype 4: Cohort Spanish Society of Liver Transplantation Cohort
Sanchez Antolin G; (...); Castells L
Article. 10.1016/j.transproceed.2016.08.034. 2016
Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO)
Rubio, MJ; (...); Santaballa, A
Article. 10.1016/j.gore.2020.100594. 2020
Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer.
Garcia, YG; (...); Gonzalez Martin A
Article. 10.1136/ijgc-2019-000256. 2019
Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C
Fernández I; (...); Londoño MC
Article. 10.1016/j.jhep.2016.12.020. 2017
EFFICACY OF TRABECTEDIN IN METASTATIC UTERINE LEIOMYOSARCOMA: A RETROSPECTIVE MULTICENTER STUDY OF THE SPANISH OVARIAN CANCER RESEARCH GROUP (GEICO)
Rubio, MJ; (...); Santaballa, A
Meeting Abstract. 2018
Endothelin-1-Mediated Drug Resistance in EGFR-Mutant Non-Small Cell Lung Carcinoma
Pulido, I; (...); Shimamura, T
Article. 10.1158/0008-5472.CAN-20-0141. 2020
Enhancing the accuracy of mid-infrared spectroscopy-based liver steatosis quantification using digital image analysis as a reference.
Rienda, Ivan; (...); Quintas, Guillermo
Article. 10.1039/d3an00324h. 2023
Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities
Buti M; (...); Gila A
Article. 10.1097/MEG.0000000000000195. 2015
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study
Martin, M; (...); Lluch, A
Article. 10.1200/JCO.2015.61.9510. 2015
Estrategias para evitar la recidiva viral B despues del trasplante hepatico.
Abstract of Published Item. 10.1016/S0210-5705(14)70067-6. 2014
Estudio comparativo de los cambios funcionales y estructurales producidos en un modelo porcino de infarto de miocardio agudo y cronico.
Hernándiz A; (...); Sepúlveda P
Article. 10.1016/j.acmx.2015.09.009. 2016
Evaluation of transjugular intrahepatic portosystemic shunt (TIPS) as a previous step to liver transplantation in pediatric patients.
Crehuet Gramatyka D; (...); Vila Carbó JJ
Article. 10.54847/cp.2022.02.12. 2022
Everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study.
Gómez-Bravo M; (...); Santoyo J
Article. 10.17235/reed.2022.8549/2021. 2022
Evolution of older patients diagnosed with early breast cancer in Spain between 1998 and 2001 included in El Alamo III project
Torregrosa, MD; (...); Ruiz, A
Article. 10.1007/s12094-019-02189-6. 2019
EVs derived from HIF-overexpressing MSC primed with a pro-inflammatory cocktail promote M2 macrophage polarization and reduce fibrosis and endothelium activation in vitro and in a mouse ulcerous colitis model.
Gomez-Ferrer, M.; (...); Sepulveda, P.
Meeting Abstract. 2021
Extending metabolome coverage for untargeted metabolite profiling of adherent cultured hepatic cells
García-Cañaveras JC; (...); Lahoz A
Article. 10.1007/s00216-015-9227-8. 2016
Extracellular vesicles from dental pulp mesenchymal stem cells modulate macrophage phenotype during acute and chronic cardiac inflammation in athymic nude rats with myocardial infarction.
Amaro-Prellezo, Elena; (...); Sepulveda, Pilar
Article. 10.1186/s41232-024-00340-7. 2024
Extracellular Vesicles Secreted by Hypoxic AC10 Cardiomyocytes Modulate Fibroblast Cell Motility.
Ontoria-Oviedo, I; (...); Sepulveda, P
Article. 10.3389/fcvm.2018.00152. 2018
Extrathoracic Aneurysms in Marfan Syndrome: A Systematic Review of the Literature.
Requejo-Garcia, Lucia; (...); Miralles-Hernandez, Manuel
Article. 10.1016/j.avsg.2022.08.005. 2022
Factors that influence the quality of metabolomics data in in vitro cell toxicity studies: a systematic survey.
Moreno-Torres, Marta; (...); Castell, Jose Vicente
Article. 10.1038/s41598-021-01652-1. 2021
FAMetA: a mass isotopologue-based tool for the comprehensive analysis of fatty acid metabolism.
Alcoriza-Balaguer MI; (...); Lahoz A
Article. 10.1093/bib/bbad064. 2023
Feasibility and outcomes of transjugular intrahepatic portosystemic shunts in infants.
Martinez-Rodrigo, Jose J.; (...); Marti-Bonmati, Luis
Article. 10.1007/s00247-022-05575-5. 2022
Feasibility and Safety of a Modified Outpatient Regimen With Intravenous/Intraperitoneal Chemotherapy for Optimally Debulked Stage III Ovarian Cancer
Bruixola G; (...); Santaballa A
Article. 10.1097/IGC.0000000000000330. 2015
Femoral insertion site of the graft used to replace the medial patellofemoral ligament influences the ligament dynamic changes during knee flexion and the clinical outcome (vol 25, pg 2443, 2017)
Sanchis-Alfonso, V; (...); Marti-Bonmati, L
Correction. 10.1007/s00167-018-5271-1. 2019
FIRST REAL CLINICAL PRACTICE DATA IN SPAIN ON SOFOSBUVIR, SIMEPREVIR AND DACLATASVIR IN POST-TRANSPLANT HCV RECURRENCE: THE HepatiC REGISTRY EXPERIENCE
Prieto, M.; (...); Forns, X.
Article. 10.1016/S0168-8278(15)30988-0. 2015
Framingham score, renal dysfunction, and cardiovascular risk in liver transplant patients
Di Maira, Tommaso; (...); Berenguer, Marina
Article. 10.1002/lt.24128. 2015
Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "ElA Alamo III" retrospective study
Marquez-Rodas, Ivan; (...); Lopez-Tarruella, Sara
Article. 10.1371/journal.pone.0184181. 2017
GEICO1601-ROLANDO trial: A multicentric single arm phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer
Fidalgo, JAP; (...); Martin, AG
Meeting Abstract. 10.1016/j.annonc.2020.08.971. 2020
GEICO1601-ROLANDO: a multicentric single arm Phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer
Perez-Fidalgo, JA; (...); Gonzalez-Martin, A
Article. 10.4155/fsoa-2018-0107. 2019
Gender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM).
Elez E; (...); Garrido P
Article. 10.1016/j.esmoop.2021.100048. 2021
General Cytotoxicity Assessment by Means of the MTT Assay.
Tolosa, L, Donato, MT, Gomez-Lechon, MJ
Article. 10.1007/978-1-4939-2074-7_26. 2015
Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population
Bosó V; (...); Aliño SF
Article. 10.1097/FTD.0b013e3182a94e65. 2014
Genotype FBN1/Phenotype relationship in a cohort of patients with Marfan syndrome.
Hernándiz A; (...); Sepúlveda P
Article. 10.1111/cge.13879. 2020
Giant Circumflex Aneurysm with Arteriovenous Fistula Surgery Guided by Three-dimensional Printing.
Blanco-Herrera OR; (...); Montero-Argudo JA
Editorial Material. 10.1016/j.athoracsur.2019.11.051. 2020
Glucose 6 phosphate dehydrogenase overexpression rescues the loss of cognition in the double transgenic APP/PS1 mouse model of Alzheimer's disease
Correas, Angela G.; (...); Vina, Jose
Article. 10.1016/j.redox.2024.103242. 2024
Glucose Starvation in Cardiomyocytes Enhances Exosome Secretion and Promotes Angiogenesis in Endothelial Cells
Garcia NA; (...); Sepúlveda P
Article. 10.1371/journal.pone.0138849. 2015
Glutamine/glutamate metabolism rewiring in reprogrammed human hepatocyte-like cells
Ballester, M; (...); Bort, R
Article. 10.1038/s41598-019-54357-x. 2019
GMP manufacturing process for allogeneic cell therapy treatment of acute myocardial infarction
Palacios, I.; (...); Rodriguez-Borlado, L.
Article. 2013
Good posttransplant outcome using donors after cardiac death (DCD) when applying strict selection criteria
de la Varga, MF; (...); Castillo, MP
Meeting Abstract. 2021
Good post-transplant outcomes using liver donors after circulatory death when applying strict selection criteria: A propensity-score matched-cohort study.
Fernandez-de la Varga, Margarita; (...); Aguilera, Victoria
Article. 10.1016/j.aohep.2022.100724. 2022
Growth-promoting and tumourigenic activity of c-Myc is suppressed by Hhex
Marfil V; (...); Bort R
Article. 10.1038/onc.2014.240. 2015
Gut Microbiota and Plasma Bile Acids Associated with Non-Alcoholic Fatty Liver Disease Resolution in Bariatric Surgery Patients.
Perez-Rubio, Alvaro; (...); Jover, Ramiro
Article. 10.3390/nu15143187. 2023
Haemophagocytic syndrome in a liver transplant patient during treatment with Telaprevir.
Rodríguez-Medina B; (...); Berenguer M
Article. 10.1016/S1665-2681(19)31305-5. 2013
HCV cirrhosis: liver volume as a non-invasive predictor of liver recovery post DAA treatment
Di Maira, T; (...); Berenguer, M
Meeting Abstract. 10.1016/S0168-8278(17)31568-4. 2017
Health-related quality of life (QoL) in platinum-resistant ovarian cancer patients treated with olaparib and pegylated liposomal doxorubicin (PLD), a multicenter single-arm phase II clinical trial (ROLANDO, GEICO-1601).
Alejandro Perez-Fidalgo, Jose; (...); Gonzalez-Martin, Antonio
Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.5549. 2021
Heart failure entails significant changes in human nucleocytoplasmic transport gene expression.
Molina-Navarro MM; (...); Rivera M
Article. 10.1016/j.ijcard.2013.03.192. 2013
Hepatic cell lines for drug hepatotoxicity testing: limitations and strategies to upgrade their metabolic competence by gene engineering.
Donato MT, Jover R, Gómez-Lechón MJ
Article. 2013
Hepatitis B surface antigen loss after discontinuing nucleos(t)ide analogue for treatment of chronic hepatitis B patients is persistent in White patients
Suarez, E; (...); Simon, MA
Article. 10.1097/MEG.0000000000001289. 2019
Hepatitis B virus quasispecies evolution after liver transplantation in patients under long-term lamivudine prophylaxis with or without hepatitis B immune globulin
Buti M; (...); Esteban R
Article. 10.1111/tid.12360. 2015
Hepatitis B virus recurrence after liver transplantation and evolution of viral quasispecies
Buti, Maria; (...); Rodriguez-Frias, Francisco
Article. 2014
Hepatitis C-related cirrhosis: Current status
Conde, I, Vinaixa, C, Berenguer, M
Review. 10.1016/j.medcli.2016.09.019. 2017
Hepatobiliary and Pancreatic: A fatal case of extensive splanchnic vein thrombosis in a patient with Covid-19.
Del Hoyo J; (...); Aguilera V
Editorial Material. 10.1111/jgh.15174. 2020
Hepatocyte transplantation program: Lessons learned and future strategies
Review. 10.3748/wjg.v22.i2.874. 2016
Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis
Bozic M; (...); Jover R
Article. 10.1016/j.jhep.2016.05.031. 2016
HIF-1 alpha and Pro-Inflammatory Signaling Improves the Immunomodulatory Activity of MSC-Derived Extracellular Vesicles
Gomez-Ferrer, M; (...); Dorronsoro, A
Article. 10.3390/ijms22073416. 2021
HIF-Overexpression and Pro-Inflammatory Priming in Human Mesenchymal Stromal Cells Improves the Healing Properties of Extracellular Vesicles in Experimental Crohn's Disease.
Gómez-Ferrer M; (...); Sepúlveda P
Article. 10.3390/ijms222011269. 2021
High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4
Mariño Z; (...); Forns, X
Article. 10.1111/liv.13470. 2017
High-content screening of drug-induced mitochondrial impairment in hepatic cells: effects of statins
Article. 10.1007/s00204-014-1334-3. 2015
High-content screening technology for studying drug-induced hepatotoxicity in cell models
Tolosa L, Gómez-Lechón MJ, Donato MT
Review. 10.1007/s00204-015-1503-z. 2015
HIV infection is not associated with increased cardiovascular (CV) risk in liver transplant (LT) recipients: a single centre comparative study
Vinaixa, C.; (...); Prieto, M.
Meeting Abstract. 2019
Human AAT gene transfer to pig liver improved by using a perfusion isolated organ endovascular procedure
Sendra L; (...); Aliño SF
Article. 10.1007/s00330-015-3792-2. 2016
Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening
Review. 10.1007/s00204-016-1756-1. 2016
Human neonatal hepatocyte transplantation induces long-term rescue of unconjugated hyperbilirubinemia in the Gunn rat
Tolosa L; (...); Gómez-Lechón MJ
Article. 10.1002/lt.24121. 2015
Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing
Article. 10.1093/toxsci/kfw078. 2016
Hydrogen Sulfide Improves Cardiomyocyte Function in a Cardiac Arrest Model
Garcia, NA; (...); Sepulveda, P
Article. 10.12659/AOT.901410. 2017
Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.
Rodríguez-Lescure Á; (...); de la Haba-Rodriguez J
Article. 10.1007/s12094-024-03411-w. 2024
Hypoxia Inducible Factor-1 alpha Potentiates Jagged 1-Mediated Angiogenesis by Mesenchymal Stem Cell-Derived Exosomes
Gonzalez-King, H; (...); Sepulveda, P
Article. 10.1002/stem.2618. 2017
Iberogast-Induced Severe Hepatotoxicity Leading to Liver Transplantation
Sáez-González E; (...); Berenguer M
Letter. 10.1038/ajg.2016.260. 2016
Identification of a Novel Synthetic Lethal Vulnerability in Non-Small Cell Lung Cancer by Co-Targeting TMPRSS4 and DDR1
Redin, E; (...); Calvo, A
Meeting Abstract. 10.1016/j.jtho.2019.08.1485. 2019
Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1
Villalba, Maria; (...); Calvo, Alfonso
Article. 10.1038/s41598-019-51066-3. 2019
Identification of a specific epigenetic signature in patients showing secondary hypertension upon anti-VEGF treatment from the GEICAM/2011-04 (BRECOL) study
de la Haba, J; (...); Rodriguez-Lescure, A
Meeting Abstract. 10.1158/1538-7445.SABCS19-P4-10-28. 2020
Identification of omega-3 oxylipins in human milk-derived extracellular vesicles with pro-resolutive actions in gastrointestinal inflammation.
Gómez-Ferrer M; (...); Sepúlveda P
Article. 10.3389/fimmu.2023.1293737. 2023
IFN gamma Regulates Activated V delta 2+T Cells through a Feedback Mechanism Mediated by Mesenchymal Stem Cells
Fechter, K; (...); Trigueros, C
Article. 10.1371/journal.pone.0169362. 2017
Immune checkpoint inhibitors as first-line treatment for brain metastases in stage IV NSCLC patients without driver mutations
Suay, Guillermo; (...); Lahoz, Agustin
Review. 10.1016/j.canlet.2024.217317. 2024
Immunohistochemical, genetic and epigenetic profiles of hereditary and triple negative breast cancers. Relevance in personalized medicine
Murria R; (...); Bolufer P
Article. 2015
Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer
Salvador-Coloma, C; (...); de Mora, JF
Article. 10.1016/j.ejca.2020.08.020. 2020
Immunosuppressive profiles in liquid biopsy predict response to neoadjuvant chemotherapy in triple negative breast cancer
Salvador-Coloma, C; (...); Santaballa, A
Meeting Abstract. 10.1158/1538-7445.SABCS18-P3-11-16. 2019
Impact of hepatitis C virus (HCV) antiviral treatment on the need for liver transplantation (LT)
Saez-Gonzalez, E; (...); Berenguer, M
Article. 10.1111/liv.13618. 2018
Improved in vivo efficacy of clinical-grade cryopreserved human hepatocytes in mice with acute liver failure
Bolonio, M.; (...); Tolosa, L.
Meeting Abstract. 2019
Improved in vivo efficacy of clinical-grade cryopreserved human hepatocytes in mice with acute liver failure.
Article. 10.1016/j.jcyt.2019.12.005. 2020
Improved Renal Function in Liver Transplant Recipients Treated for Hepatitis C Virus With a Sustained Virological Response and Mild Chronic Kidney Disease
Blé M; (...); Berenguer M
Article. 10.1002/lt.23756. 2014
In vitro model of atrial fibrillation: investigating the initiation and maintenance mechanisms of atrial remodeling using hiPSC-derived atrial cardiomyocytes
Casini, M.; (...); Sepulveda, P.
Meeting Abstract. 2023
In vitro modulation of the cytochrome P450 and ABCB1/P-glycoprotein activities of the aqueous extract of Allophylus cominia (L) Sw. leaves.
Pérez CL; (...); Rodeiro I
Article. 10.1515/dmpt-2017-0020. 2017
In vitro validation of biomedical polyester-based scaffolds: Poly(lactide-co-glycolide) as model-case
Gil-Castell, O; (...); Ribes-Greus, A
Article. 10.1016/j.polymertesting.2018.01.027. 2018
In vitro/in vivo screening of oxidative homeostasis and damage to DNA, protein, and lipids using UPLC/MS-MS
Carretero, A; (...); Lahoz, A
Article. 10.1007/s00216-014-7983-5. 2014
Incidence of Development of Obesity After Heart Transplantation According to the Calcineurin Inhibitor
López-Vilella R; (...); Montero-Argudo A
Article. 10.1016/j.transproceed.2014.11.025. 2015
Induced pluripotent stem cells for the treatment of liver diseases: challenges and perspectives from a clinical viewpoint
Pareja, E, Gomez-Lechon, MJ, Tolosa, L
Review. 10.21037/atm.2020.02.164. 2020
Integration of new biological and physical retrospective dosimetry methods into EU emergency response plans - joint RENEB and EURADOS inter-laboratory comparisons
Ainsbury, E; (...); Woda, C
Article. 10.1080/09553002.2016.1206233. 2017
Interindividual variation in response to xenobiotic exposure established in precision-cut human liver slices
Jetten MJ; (...); Kleinjans JC
Article. 10.1016/j.tox.2014.06.007. 2014
Intracellular role of IL - 6 in mesenchymal stromal cell immunosuppression and proliferation
Dorronsoro, Akaitz; (...); Trigueros C
Article. 2020
Intracellular role of IL-6 in mesenchymal stromal cell immunosuppression and proliferation.
Dorronsoro, Akaitz; (...); Trigueros, Cesar
Article. 10.1038/s41598-020-78864-4. 2020
Involvement of the-420C > G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy
Hernández-Romero D; (...); Marín F
Article. 10.1111/joim.12334. 2015
Is hepatitis B immunoglobulin necessary for hepatitis D prophylaxis after liver transplantation? A retrospective multicenter study of a cohort of 174 patients
Rodriguez-Tajes, Sergio; (...); Forns, Xavier
Meeting Abstract. 2020
Isolation and Lipidomic Screening of Human Milk Extracellular Vesicles.
Ramos-Garcia, Victoria; (...); Kuligowski, Julia
Article. 10.1007/978-1-0716-2699-3_18. 2023
Isolation of extracellular vesicles derived from mesenchymal stem cells by ultracentrifugation and tangential flow filtration followed by size-exclusion chromatography: a functional comparison
Amaro-Prellezo, E.; (...); Sepulveda, P.
Meeting Abstract. 2021
Lack of effect of CMV reactivation in the outcome of HCV-infected liver transplant(LT)patients
Aguilera, Victoria; (...); Berenguer, Marina
Article. 2015
LC-MS untargeted metabolomic analysis of drug-induced hepatotoxicity in HepG2 cells
García-Cañaveras JC; (...); Lahoz A
Article. 10.1002/elps.201500095. 2015
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial
Manns, M; (...); SOLAR-2 Investigators
Article. 10.1016/S1473-3099(16)00052-9. 2016
LipidMS 3.0: an R-package and a web-based tool for LC-MS/MS data processing and lipid annotation.
Alcoriza-Balaguer MI; (...); Lahoz, Agustin
Article. 10.1093/bioinformatics/btac581. 2022
LipidMS: An R Package for Lipid Annotation in Untargeted Liquid Chromatography-Data Independent Acquisition-Mass Spectrometry Lipidomics
Alcoriza-Balaguer, MI; (...); Lahoz, A
Article. 10.1021/acs.analchem.8b03409. 2019
Lipid-Specific Immunoglobulin M Bands in Cerebrospinal Fluid Are Associated with a Reduced Risk of Developing Progressive Multifocal Leukoencephalopathy during Treatment with Natalizumab
Villar LM; (...); Álvarez-Cermeño JC
Article. 10.1002/ana.24345. 2015
Long term follow-up in HCV infected patients with end stage chronic kidney disease after DAA therapy
Martinez-Camprecios, J; (...); Buti, M
Meeting Abstract. 2021
Long-term and mechanistic evaluation of drug-induced liver injury in Upcyte human hepatocytes.
Tolosa, L; (...); Donato, MT
Article. 10.1007/s00204-018-2349-y. 2019
Long-Term Complications After Liver Transplantation: Results at 15 Years After Transplantation
Berenguer, Marina; (...); Prieto, Martn
Article. 2015
Long-Term Effectiveness, Safety, and Patient- Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study
Roche B; (...); Samuel D
Article. 10.12659/AOT.936162. 2022
Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy
Martinez-Camprecios, Joan; (...); Buti, Maria
Article. 10.1016/j.gastrohep.2022.12.004. 2023
Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Alamo IV registry.
Martin, Miguel; (...); Aguiar-Bujanda, David
Article. 10.1007/s10549-023-07002-1. 2023
Long-term reoperation in Tetralogy of Fallot: is it possible to preserve the native pulmonary valve again?
Martineza, Felix Serrano; (...); Molinab, Esteban Peiro
Article. 10.1016/j.circv.2022.01.009. 2022
Los elementos decorativos ambientales en el Area de Imagen Medica mejoran la percepcion de agradabilidad del paciente.
Garcia Marcos R; (...); Diaz Dho R
Abstract of Published Item. 10.1016/j.rx.2012.07.006. 2014
Low density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial Hypercholesterolemia modelling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection
Caron, J; (...); Dubart-Kupperschmitt, A
Meeting Abstract. 10.1016/S0168-8278(18)30382-9. 2018
Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.
Caron J; (...); Dubart-Kupperschmitt A
Article. 10.1186/s13287-019-1342-6. 2019
Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study.
Kristeleit, Rebecca; (...); Subbiah, Vivek
Article. 10.1007/s10637-023-01383-2. 2023
Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket study.
Longo-Munoz, Federico; (...); Subbiah, Vivek
Article. 10.1016/j.ejca.2022.06.024. 2022
Mammalian cell metabolomics: experimental design and sample preparation.
León Z; (...); Lahoz A
Article. 10.1002/elps.201200605. 2013
Mesenchymal Stem Cell Migration and Proliferation Are Mediated by Hypoxia-Inducible Factor-1 alpha Upstream of Notch and SUMO Pathways
Ciria, M; (...); Sepulveda, P
Article. 10.1089/scd.2016.0331. 2017
Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs
Gomez-Lechon, MJ, Tolosa, L, Donato, MT
Review. 10.1002/jat.3277. 2016
METABOLIC DEPENDENCY OF CHORISMATE IN PLASMODIUM FALCIPARUM
Valenciano, AL; (...); Cassera, MB
Meeting Abstract. 2018
Metabolic syndrome before liver transplantation: does it have an impact on post liver transplantation outcomes?
Herreras Lopez, Julia; (...); Aguilera, Victoria
Article. 10.17235/reed.2022.8384/2021. 2022
Metabolic vulnerabilities of mesenchymal-like EGFR-mutant NSCLC cells with acquired resistance to tyrosine kinase inhibitors
Pulido, I; (...); Carretero, J
Meeting Abstract. 10.1158/1538-7445.AM2018-LB-099. 2018
Metabolomics discloses donor liver biomarkers associated with early allograft dysfunction
Cortes M; (...); Lahoz A
Article. 10.1016/j.jhep.2014.04.023. 2014
Metabolomics of Plasma in XLH Patients with Arterial Hypertension: New Insights into the Underlying Mechanisms
Lopez-Romero, Luis Carlos; (...); Hernandez-Jaras, Julio
Article. 10.3390/ijms25063545. 2024
Metabolomics-based strategy to assess drug hepatotoxicity and uncover the mechanisms of hepatotoxicity involved.
Martínez-Sena T; (...); Castell JV
Article. 10.1007/s00204-023-03474-8. 2023
Methods for analysis of specific DNA methylation status.
Pajares MJ; (...); Sandoval J
Article. 10.1016/j.ymeth.2020.06.021. 2020
Methylation of tumor suppressor genes is related with copy number aberrations in breast cancer
Murria R; (...); Bolufer P
Article. 2015
MICRORNA EXPRESSION PROFILE IN EPICARDIAL FAT IN SUDDEN CARDIAC DEATH FROM CORONARY ARTERY DISEASE
Braza-Boils, A.; (...); Zorio, E.
Article. 2014
Mild Muscle Mitochondrial Fusion Distress Extends Drosophila Lifespan through an Early and Systemic Metabolome Reorganization.
Tapia A; (...); Galindo MI
Article. 10.3390/ijms222212133. 2021
miR-133a Enhances the Protective Capacity of Cardiac Progenitors Cells after Myocardial Infarction
Izarra A; (...); Bernad A
Article. 10.1016/j.stemcr.2014.10.010. 2014
miR-4732-3p in Extracellular Vesicles From Mesenchymal Stromal Cells Is Cardioprotective During Myocardial Ischemia
Sánchez-Sánchez R; (...); Sepúlveda P
Article. 10.3389/fcell.2021.734143. 2021
miRNA-4732-3p as a possible therapeutic tool for the treatment of myocardial ischemia
Sanchez-Sanchez, R.; (...); Sepulveda, P.
Meeting Abstract. 2021
miRNAs Related to Immune Checkpoint Inhibitor Response: A Systematic Review.
García-Giménez JL; (...); Mena-Molla S
Article. 10.3390/ijms25031737. 2024
Mitral repair results in endocarditis
Dominguez-Massa, C; (...); Montero-Argudo, JA
Article. 10.1016/j.circv.2020.08.005. 2020
Model-based contextualization of in vitro toxicity data quantitatively predicts in vivo drug response in patients
Thiel, C; (...); Kuepfer, L
Article. 10.1007/s00204-016-1723-x. 2017
Modeling Cardiotoxicity in Pediatric Oncology Patients Using Patient-Specific iPSC-Derived Cardiomyocytes Reveals Downregulation of Cardioprotective microRNAs.
Reinal, Ignacio; (...); Sepulveda, Pilar
Article. 10.3390/antiox12071378. 2023
Modeling Transposition of the Great Arteries with Patient-Specific Induced Pluripotent Stem Cells.
Ontoria-Oviedo, Imelda; (...); Sepulveda, Pilar
Article. 10.3390/ijms222413270. 2021
Modelos Celulares hepáticos avanzados para el estudio preclíico del metabolismo y la hepatotoxicdad de fármacos.
MARÍA JOSÉ GÓMEZ-LECHÓN MOLINER
Article. 2017
Molecular characterization of Hepatitis C virus resistance-associated substitutions after interferon-free treatment failure by massive parallel sequencing
Chen, Q; (...); Quer, J
Meeting Abstract. 10.1016/S0168-8278(17)31950-5. 2017
Molecular characterization of pregnancy-associated breast cancer and insights on timing from GEICAM-EMBARCAM study.
Pena-Enriquez, Regina; (...); de la Haba-Rodriguez, Juan
Article. 10.1038/s41523-025-00718-x. 2025
Mortality risk score in aortic surgery. Initial experience with the implementation of a new predictive model
Berbel, A; (...); Montero, JA
Article. 10.1016/j.circv.2014.10.009. 2015
mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels).
Riveiro-Barciela, Mar; (...); Esteban, Rafael
Article. 10.1016/j.gastrohep.2023.01.010. 2023
Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer
Romero, I; (...); Gonzalez-Martin, A
Article. 10.1097/CAD.0000000000000794. 2019
Multidisciplinary consensus on the criteria for fertility preservation in cancer patients.
Santaballa, A.; (...); Manau-Trullas, D.
Article. 10.1007/s12094-021-02699-2. 2022
Multi-omics HeCaToS dataset of repeated dose toxicity for cardiotoxic & hepatotoxic compounds.
Verheijen, Marcha; (...); HeCaToS Consortium
Article. 10.1038/s41597-022-01825-1. 2022
Neonatal Livers: A Source for the Isolation of Good-Performing Hepatocytes for Cell Transplantation
Tolosa L; (...); Gómez-Lechón MJ
Article. 10.3727/096368913X669743. 2014
Neutrophil-lymphocyte ratio predicts survival in platinum-resistant ovarian cancer patients treated with olaparib and pegylated liposomal doxorubicin (PLD): Stratified analysis from the phase II clinical trial ROLANDO, GEICO-1601
Fidalgo, JAP; (...); Gonzalez-Martin, A
Meeting Abstract. 10.1016/j.annonc.2021.08.1177. 2021
New Cell Adhesion Molecules in Human Ischemic Cardiomyopathy. PCDHGA3 Implications in Decreased Stroke Volume and Ventricular Dysfunction
Ortega, Ana; (...); Rosello-Lleti, Esther
Article. 10.1371/journal.pone.0160168. 2016
New clinical trials regulation in Spain: analysis of royal decree 1090/2015
Martin Jimenez M; (...); Segui Palmer MA
Article. 10.1007/s12094-016-1550-9. 2017
New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease
Lopez-Riera, M; (...); Jover, R
Article. 10.3389/fpahr.2017.00003. 2017
NIRAPARIB AS MAINTENANCE THERAPY IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: A GEICO STUDY WITHIN THE SPANISH EXTENDED ACCESS PROGRAM
Cueva Banuelos, J. F.; (...); Gonzalez-Martin, A.
Meeting Abstract. 10.1136/ijgc-2021-ESGO.447. 2021
Non-classical Notch signaling by MDA-MB-231 breast cancer cell-derived small extracellular vesicles promotes malignancy in poorly invasive MCF-7 cells.
Gonzalez-King, Hernan; (...); Garcia, Nahuel A.
Article. 10.1038/s41417-021-00411-8. 2022
Non-Invasive Infections Diagnosis in Lung Transplant Recipients in Exhaled Breath Condensate
Ibanez-Martinez, E.; (...); Sole-Jover, A.
Meeting Abstract. 2021
Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers
Lopez-Riera, M; (...); Jover, R
Article. 10.1038/s41598-018-28854-4. 2018
Normalization approaches for extracellular vesicle-derived lipidomic fingerprints - A human milk case study
Ten-Domenech, Isabel; (...); Kuligowski, Julia
Article. 10.1016/j.chemolab.2024.105070. 2024
Notch ligand Jagged 1 in MSC-HIF exosomes and its angiogenic potential
Gonzalez-King, H.; (...); Sepulveda, P.
Meeting Abstract. 2016
Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)
Perez-Fidalgo, JA; (...); Gonzalez-Martin, A
Article. 10.1016/j.esmoop.2021.100212. 2021
Oncostatin M-Enriched Small Extracellular Vesicles Derived from Mesenchymal Stem Cells Prevent Isoproterenol-Induced Fibrosis and Enhance Angiogenesis.
Tejedor, Sandra; (...); Sepulveda, Pilar
Article. 10.3390/ijms24076467. 2023
Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03.
Garcia-Donas, Jesus; (...); Grande, Enrique
Article. 10.1007/s12094-023-03085-w. 2023
Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome
Fernandez-Santos, Maria Eugenia; (...); Zapata, Agustin G.
Article. 10.3389/fimmu.2022.918565. 2022
Optimization of oral chemotherapy in outpatient clinics in Spain: results from a survey of the Spanish Society of Medical Oncology (SEOM)
Santaballa, A; (...); Alba, E
Article. 10.1007/s12094-018-1951-z. 2019
OReO/ENGOT Ov-38 trial: Impact of maintenance olaparib rechallenge according to ovarian cancer patient prognosis-An exploratory joint analysis of the BRCA and non-BRCA cohorts.
Selle, Frederic; (...); Pujade-Lauraine, Eric
Meeting Abstract. 2022
Out of Milan criteria and worse intetion to treat results at large liver transplant center
Lopez, JH; (...); Haym, MB
Meeting Abstract. 10.1016/S0168-8278(18)30613-5. 2018
Outcomes of single versus double hormone receptor-positive breast cancer. A GEICAM/9906 sub-study
Ethier, JL; (...); Martin, M
Article. 10.1016/j.ejca.2018.02.018. 2018
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study.
Martin, Miguel; (...); Gil-Gil, Miguel
Article. 10.1016/j.ejca.2022.03.006. 2022
OVERCOMING BARRIERS TO CARE FOR DELTA INFECTED PATIENTS
Carvalho-Gomes, Angela; (...); Berenguer, Marina
Meeting Abstract. 2022
Overcoming barriers to care for Delta infected patients
Bono, Ariadna; (...); Berenguer, Marina
Meeting Abstract. 2023
Over-Expression of HIF-1A In Mesenchymal Stromal Cells Increases Human CD34+Cells Clonogenic Capacity in Vitro And Engraftment Ability in A Xenotransplantation Model
Preciado, S; (...); Sanchez-Guijo, F
Meeting Abstract. 2021
Overexpression of hypoxia-inducible factor 1 alpha improves immunomodulation by dental mesenchymal stem cells
Martinez, VG; (...); Vicente, A
Article. 10.1186/s13287-017-0659-2. 2017
Oxylipin profile of human milk and human milk-derived extracellular vesicles.
Albiach-Delgado, Abel; (...); Quintas, Guillermo
Article. 10.1016/j.aca.2024.342759. 2024
Percutaneous closure of ventricular septal defect with the KONAR-MF device
Alvarez-Fuente, Maria; (...); Del Cerro, Maria Jesus
Article. 10.24875/RECICE.M22000277. 2022
Performance of the fibroscan and other noninvasive scales for detecting hepatic fibrosis in patients with nonalcoholic fatty liver disease
Saez, E; (...); Zaragoza, A
Meeting Abstract. 10.1016/S0168-8278(17)30585-8. 2017
Pharmacological senolysis reduces doxorubicin-induced cardiotoxicity and improves cardiac function in mice.
Lerida-Viso, Araceli; (...); Martinez-Manez, Ramon
Article. 10.1016/j.phrs.2022.106356. 2022
Phase II clinical trial assessing the efficacy of enzalutamide in advanced non-resectable granulosa cell ovarian tumors: The GREKO III study (GETHI2016-01).
García-Donas J; (...); Navarro P
Article. 10.1016/j.ygyno.2024.10.019. 2024
Phase II randomized trial of neoadjuvant (NA) chemotherapy (CT) with or without bevacizumab (Bev) in advanced epithelial ovarian cancer (EOC) (GEICO 1205/NOVA TRIAL)
Garcia, YG; (...); Martin, AG
Meeting Abstract. 10.1200/JCO.2017.35.15_suppl.5508. 2017
Phenotypic and genotypic characterization of drug-induced liver injury (DILI) with autoimmune features
Stephens, C.; (...); Andrade, Raul J.
Article. 2015
Pilot validation study of a rapid test in oral fluid for population screening of hepatitis C virus infection
Pallares, C; (...); Berenguer, M
Meeting Abstract. 10.1016/S0168-8278(17)31165-0. 2017
Plasma mutational burden in PIK3CA and TP53 independently predicts early progression in patients with HR+/HER2-metastatic breast cancer (MBC) enrolled in the GEICAM/2014-12 FLIPPER trial
Gustavo, Federico; (...); Albanell, Joan
Meeting Abstract. https://doi.org/10.1200/JCO.2024.42.16_suppl.1029. 2024
Plasmatic Membrane Expression of Adhesion Molecules in Human Cardiac Progenitor/Stem Cells Might Explain Their Superior Cell Engraftment after Cell Transplantation.
Ontoria-Oviedo I; (...); Sepúlveda P
Article. 10.1155/2020/8872009. 2020
Platelet rich plasma and plasma rich in growth factors for split-thickness skin graft donor site treatment in the burn patient setting: A randomized clinical trial.
García-Sánchez JM; (...); Pérez-Del-Caz MD
Article. 10.1016/j.burns.2021.10.001. 2021
PLEIOTROPIC EFFECT OF MIR-146A CAUSES PLATELET HYPERREACTIVITY AND THROMBOSIS THROUGH METABOLIC ICA REPROGRAMMING
Sonia, Aguila; (...); Constantino, Martinez
Meeting Abstract. 2021
Plk1 expression & efficacy of palbociclib in advanced hormonal receptor-positive breast cancer patients from PEARL study (GEICAM 2012-03)
Guerrero-Zotano, A; (...); Martin, M
Meeting Abstract. 2021
Podocalyxin-like protein 1 is a relevant marker for human c-kit(pos) cardiac stem cells
Moscoso I; (...); Bernad A
Article. 10.1002/term.1795. 2016
Polycaprolactone/gelatin-based scaffolds with tailored performance: in vitro and in vivo validation
Gil-Castell, O; (...); Ribes-Greus, A
Article. 10.1016/j.msec.2019.110296. 2020
Polymer Conjugation of Docosahexaenoic Acid Potentiates Cardioprotective Therapy in Preclinical Models of Myocardial Ischemia/Reperfusion Injury.
Tejedor S; (...); Vicent MJ
Article. 10.1002/adhm.202002121. 2021
Population screening using a point-of-care test reveals unexpectedly low prevalence of active HCV infection in Spain
Carvalho-Gomes, A; (...); Berenguer, M
Meeting Abstract. 2017
Postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate or high risk endometrial cancer: The ENGOT-EN2/DGCG trial.
Mirza, MR; (...); Amant, F
Meeting Abstract. 10.1200/JCO.2017.35.15_suppl.TPS5613. 2017
Postoperative prognostic impact of replacement fibrosis in patients with aortic valve stenosis
Munoz, BI; (...); Serrano, RP
Meeting Abstract. 2020
Postpartum hemorrhage with pelvic arterial embolization, study of 33 cases
Aguilar-Crespo A; (...); Perales-Marín A
Article. 10.1080/14767058.2017.1387527. 2019
Potency of Human Cardiosphere-Derived Cells from Patients with Ischemic Heart Disease Is Associated with Robust Vascular Supportive Ability
Harvey, E; (...); Martin-Rendon, E
Article. 10.1002/sctm.16-0229. 2017
Preclinical and clinical development of palbociclib and future perspectives
de Duenas, EM; (...); Llombart-Cussac, A
Review. 10.1007/s12094-018-1850-3. 2018
Pre-diagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma.
Stepien, Magdalena; (...); Jenab, Mazda
Article. 10.1002/ijc.33885. 2022
Pre-diagnostic plasma bile acid levels and colon cancer risk: A prospective study.
Kühn T; (...); Kaaks R
Article. 10.1093/jnci/djz166. 2020
Predicting drug-induced cholestasis: preclinical models
Petrov, PD; (...); Jover, R
Review. 10.1080/17425255.2018.1487399. 2018
Predictive Analysis of Cardiac Resynchronization Therapy Response by means of the ECG
Ortigosa, N; (...); Galbis, A
Proceedings Paper. 2016
Preparo Mi Rotacin Por, complemento virtual de la formacin MIR en Pediatra.
Hijano Bandera F; (...); Coordinadores de Continuum
Abstract of Published Item. 10.1016/j.anpedi.2019.10.001. 2019
Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review.
Salloum FN; (...); López-Fernández T
Article. 10.1016/j.jaccao.2023.08.003. 2023
Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudy
Templeton, AJ; (...); GEICAM Study Investigators
Article. 10.1007/s12094-018-1885-5. 2018
Prognostic value and clinical predictors of intramyocardial hemorrhage measured by CMR T2* sequences in STEMI.
Ferré-Vallverdú M; (...); Igual-Muñoz B
Article. 10.1007/s10554-020-02142-7. 2021
Protease inhibitors impair renal function in HCV-infected immunocompetent patients
Fernandez-Carrillo, Carlos; (...); Luis Calleja, Jose
Meeting Abstract. 2014
Quality of life (QoL) with fulvestrant (FUL)/palbociclib (PAL) versus FUL/placebo (PBO) in postmenopausal women with hormone receptor (HR)+/HER2-endocrine sensitive advanced breast cancer (ABC): Results from GEICAM/2014-12 (FLIPPER) study
Tibau, A; (...); Albanell, J
Meeting Abstract. 10.1016/j.annonc.2021.03.108. 2021
Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial.
Tibau, Ariadna; (...); Albanell, Joan
Article. 10.1177/17588359221148921. 2023
Radioembolization in patients with hepatocellular carcinoma: a series of 53 cases.
Oliván-Sasot P; (...); Olivas-Arroyo C
Article. 10.1016/j.rx.2020.09.012. 2020
Radioembolization in patients with hepatocellular carcinoma: a series of 53 cases.
Olivan-Sasot, P; (...); Olivas-Arroyo, C
Article. 10.1016/j.rxeng.2021.03.001. 2023
Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2-advanced breast cancer: GEICAM/2014-12 (FLIPPER).
Albanell, J.; (...); Rojo, F.
Article. 10.1016/j.ejca.2021.11.010. 2022
Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study
Buti, M; (...); Esteban, R
Article. 10.1371/journal.pone.0184550. 2017
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.
Harter P; (...); du Bois A
Article. 10.1056/NEJMoa2103294. 2021
Real-world clinical practice patterns and outcomes for advanced ovarian cancer in Spain (GEICO-42-R study)
Redondo, Andres; (...); Gonzalez-Martin, Antonio
Article. 10.31083/j.ejgo4206163. 2021
Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection
Crespo, J; (...); Spanish Group for the Study of the Use of Direct-acting Drugs Hepatitis C Collab
Article. 10.1016/j.cgh.2017.02.020. 2017
Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme.
Cueva, Juan F.; (...); Gonzalez-Martin, Antonio
Article. 10.1016/j.ejca.2022.12.023. 2022
Recommendations of everolimus use in liver transplant
Rubin Suarez, Angel; (...); Prieto Castillo, Martin
Review. 10.1016/j.gastrohep.2017.05.008. 2017
Regenerative cell therapy for the treatment of hyperbilirubinemic Gunn rats with fresh and frozen human induced pluripotent stem cells-derived hepatic stem cells.
Fourrier A; (...); Nguyen TH
Article. 10.1111/xen.12544. 2020
Relationship of immunohistochemistry, copy number aberrations and epigenetic disorders with BRCAness pattern in hereditary and sporadic breast cancer
Estal, RM; (...); Gilabert, PB
Article. 10.1007/s10689-015-9864-2. 2016
Reliable assessment of carbon black nanomaterial of a variety of cell culture media for in vitro toxicity assays by asymmetrical flow field-flow fractionation.
Boughbina-Portoles, Aaron; (...); Campins-Falco, Pilar
Article. 10.1007/s00216-023-04597-8. 2023
Replied to "Some remarks to SEOM clinical guidelines on cardiovascular toxicity (2018)".
Virizuela JA; (...); Fernández TL
Letter. 10.1007/s12094-019-02173-0. 2019
Repression of the Nuclear Receptor Small Heterodimer Partner by Steatotic Drugs and in Advanced Nonalcoholic Fatty Liver Disease
Article. 10.1124/mol.114.096313. 2015
Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer.
Alvarez-Lopez I; (...); Santaballa Bertrán A
Review. 10.1007/s12094-019-02269-7. 2020
Reviewing the metabolome coverage provided by LC-MS: Focus on sample preparation and chromatography-A tutorial
Review. 2021
Reviewing the metabolome coverage provided by LC-MS: Focus on sample preparation and chromatography-A tutorial.
Article. 10.1016/j.aca.2020.12.025. 2021
RNA Sequencing Analysis and Atrial Natriuretic Peptide Production in Patients with Dilated and Ischemic Cardiomyopathy
Tarazón E; (...); Portolés M
Article. 10.1371/journal.pone.0090157. 2014
RNA-sequencing analysis reveals new alterations in cardiomyocyte cytoskeletal genes in patients with heart failure
Herrer I; (...); Portolés M
Article. 10.1038/labinvest.2014.54. 2014
Role of miRNAs as epigenetic regulators of immune checkpoints in lung cancer immunity.
Canovas-Cervera, Irene; (...); Mena-Molla, Salvador
Article. 10.1016/bs.ircmb.2024.08.002. 2025
Role of the receptor for advanced glycation end products (RAGE) in blood as a potential biomarker for progression to olaparib: A post hoc analysis of patients with platinum-resistant ovarian cancer (PROC) treated in the ROLANDO-GEICO 1601 trial
Perez-Fidalgo, Jose Alejandro; (...); Gonzalez-Martin, Antonio
Meeting Abstract. 2024
RpeakChrom: Novel R package for the automated characterization and optimization of column efficiency in high-performance liquid chromatography analysis
Peris-Diaz, MD; (...); Lahoz, A
Article. 10.1002/elps.201700180. 2017
Rucaparib for PARP inhibitor-pretreated ovarian cancer: A GEICO retrospective subgroup analysis from the Spanish Rucaparib Access Program.
Yubero, Alfonso; (...); Gonzalez-Martin, Antonio
Case Reports. 10.1016/j.gore.2023.101211. 2023
Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain - A GEICO study
Yubero, Alfonso; (...); Gonzalez-Martin, Antonio
Article. 10.1186/s12885-022-10191-5. 2022
SEOM clinical guideline for secondary prevention (2019).
Santaballa A; (...); Bayo J
Article. 10.1007/s12094-020-02302-0. 2020
SEOM Clinical Guideline in ovarian cancer (2016)
Santaballa, A; (...); Romero, I
Article. 10.1007/s12094-016-1588-8. 2016
SEOM Clinical Guideline of fertility preservation and reproduction in cancer patients (2016)
Munoz M; (...); Blasco A
Article. 10.1007/s12094-016-1587-9. 2016
SEOM clinical guidelines for endometrial cancer (2017)
Santaballa, A; (...); Gonzalez-Martin, A
Article. 10.1007/s12094-017-1809-9. 2018
SEOM clinical guidelines for endometrial cancer (2017) (vol 20, pg 29, 2018)
Santaballa, A; (...); Gonzalez-Martin, A
Correction. 10.1007/s12094-018-1842-3. 2018
SEOM clinical guidelines in gestational trophoblastic disease (2017)
Santaballa, A; (...); Garcia-Martinez, E
Article. 10.1007/s12094-017-1793-0. 2018
SEOM clinical guidelines on cardiovascular toxicity (2018)
Virizuela, JA; (...); Fernandez, TL
Article. 10.1007/s12094-018-02017-3. 2019
SEOM clinical guidelines to primary prevention of cancer (2018).
Bayo J; (...); Santaballa A
Article. 10.1007/s12094-018-02016-4. 2019
SEOM guidelines 2016: an update
Santaballa, A, Martin, M
Editorial Material. 10.1007/s12094-016-1592-z. 2016
SEOM-GEICO clinical guidelines on endometrial cancer (2021).
Barretina-Ginesta MP; (...); Rubio-Pérez MJ
Article. 10.1007/s12094-022-02799-7. 2022
SERCA2a as non-invasive biomarker of heart transplant rejection
Rosello-Lleti, EE; (...); Rivera, M
Meeting Abstract. 2017
Sex Differences in the Efficacy of Immune Checkpoint Inhibitors in Neoadjuvant Therapy of Non-Small Cell Lung Cancer: A Meta-Analysis
Suay, Guillermo; (...); Juan-Vidal, Oscar
Review. 10.3390/cancers15184433. 2023
Short-term mechanical circulatory support
Bertolin, LD, Puerta, ST, Argudo, JAM
Article. 10.1016/j.circv.2016.06.007. 2016
Silencing of hepatic fate-conversion factors induce tumorigenesis in reprogrammed hepatic progenitor-like cells
Serrano F; (...); Bort R
Article. 10.1186/s13287-016-0349-5. 2016
SIMILAR POST-TRANSPLANT OUTCOMES USING DONORS AFTER CARDIAC DEATH WHEN APPLYING STRICT SELECTION CRITERIA
de la Varga, MF; (...); Aguilera, V
Meeting Abstract. 2021
SNPs and taxane toxicity in breast cancer patients
Bosó V; (...); Aliño SF
Article. 10.2217/PGS.14.127. 2014
Sofosbuvir Compassionate Use Program for Patients With Severe Recurrent Hepatitis C After Liver Transplantation
Forns X; (...); Habersetzer F
Article. 10.1002/hep.27681. 2015
Sparse N-way partial least squares by L1-penalization
Hervas, D; (...); Ferrer, A
Article. 10.1016/j.chemolab.2019.01.004. 2019
Sparse N-way partial least squares with R package sNPLS
Hervas, D.; (...); Ferrer, A.
Article. 10.1016/j.chemolab.2018.06.005. 2018
Starkeya nomas sp. nov., a prosthecate and budding bacterium isolated from an immunocompromized patient.
Sahuquillo-Arce JM; (...); López-Hontangas JL
Article. 10.1099/ijsem.0.005805. 2023
STEROID HORMONE SIGNALING MAY REGULATE HOMEOSTASIS OF POLYQ-CONTAINING PROTEINS IN C. ELEGANS
Gomez-Escribano, A. P.; (...); Vazquez-Manrique, R.
Meeting Abstract. 10.1136/jnnp-2018-EHDN.26. 2018
Studying Closed Hydrodynamic Models of "In Vivo" DNA Perfusion in Pig Liver for Gene Therapy Translation to Humans
Sendra L; (...); Aliño SF
Article. 10.1371/journal.pone.0163898. 2016
Subtype-specific differentiation of atrial and ventricular cardiomyocytes from human iPSCs
Casini, M.; (...); Sepulveda, P.
Meeting Abstract. 2021
Superior outcomes using normothermic regional perfusion in cDCD liver transplantation
Hessheimer, A; (...); Fondevila, C
Meeting Abstract. 2018
Survey to evaluate the implementation of the recommendations on the comprehensive diagnosis of viral hepatitis in a single extraction: where are we?
Cabezas, Joaquin; (...); Crespo, Javier
Meeting Abstract. 2023
SURVEY TO EVALUATE THE IMPLEMENTATION OF THE RECOMMENDATIONS ON THE COMPREHENSIVE DIAGNOSIS OF VIRAL HEPATITIS IN A SINGLE EXTRACTION: WHERE ARE WE?
Cabezas, Joaquin; (...); Crespo Garcia, Javier
Meeting Abstract. 2023
Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry).
Lopez-Tarruella S; (...); Carrasco E
Article. 10.1038/s41598-019-55765-9. 2019
Systematic Implantation of Pacemaker/ICDs under Active Oral Anticoagulation Irrespective of Patient's Individual Preoperative Thromboembolic Risk
Cano Ó; (...); Martínez-Dolz L
Article. 10.1111/pace.12613. 2015
Takayasu's arteritis associated with Crohn's disease.
Tung Chen Y; (...); Nos Mateu P
Article. 10.1016/j.rce.2014.01.012. 2014
Takeuchi technique in the anomalous origin of the left coronary artery from the pulmonary artery.
Domínguez-Massa C; (...); Hornero-Sos F
Article. 10.24875/ACME.M19000044. 2019
Targeted Disruption of the SUCNR1 Metabolic Receptor Leads to Dichotomous Effects on Obesity
McCreath KJ; (...); Cervera AM
Article. 10.2337/db14-0346. 2015
Targeting ELOVL6 to disrupt c-MYC driven lipid metabolism in pancreatic cancer enhances chemosensitivity
Garcia, Ana Garcia; (...); Sanchez-Arevalo Lobo, Victor Javier
Article. 10.1038/s41467-025-56894-8. 2025
Tecnica de Takeuchi en el origen anmalo de la arteria coronaria izquierda de la arteria pulmonar.
Domínguez-Massa C; (...); Hornero-Sos F
Article. 10.24875/ACM.M19000033. 2019
TENOFOVIR FOR THE PROPHYLAXIS OF HBV REACTIVATION IN ANTI-HBC-POSITIVE PATIENTS WITH HEMATOLOGIC MALIGNANCIES TREATED WITH RITUXIMAB: PRELIMINARY RESULTS OF A RANDOMIZED STUDY (PREBLIN STUDY)
Buti, M.; (...); Esteban, R.
Article. 10.1016/S0168-8278(14)61200-9. 2014
TENOFOVIR MONOTHERAPY VERSUS LAMIVUDINE PLUS ADEFOVIR IN LAMIVUDINE-FAILURE PATIENTS RESCUED WITH LAMIVUDINE PLUS ADEFOVIR COMBINATION: INTERIM ANALYSIS OF THE TENOSIMP-B CLINICAL TRIAL
Jorquera, F.; (...); Rodriguez, M.
Article. 10.1016/S0168-8278(14)61201-0. 2014
Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study
Rodriguez, M; (...); TENOSIMP-B Res Grp
Article. 10.3748/wjg.v23.i41.7459. 2017
TESTING CHEMICAL CARCINOGENICITY BY USING A TRANSCRIPTOMICS HEPARG-BASED MODEL?
Doktorova TY; (...); Rogiers V
Article. 2014
The ART-SCORE is not an effective tool for optimizing patient selection for DEB-TACE retreatment. A multicentre Spanish study
Pipa-Muniz, M; (...); Varela, M
Article. 10.1016/j.gastrohep.2017.05.009. 2017
The combination of cell and gene therapy as new generation tool to boost MSCs immunosuppressive and tissue regeneration properties
Dorronsoro, A; (...); Sepulveda, P
Meeting Abstract. 2017
The Development of a Non-Invasive Screening Method Based on Serum microRNAs to Quantify the Percentage of Liver Steatosis
Soluyanova, Polina; (...); Jover, Ramiro
Article. 10.3390/biom14111423. 2024
The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease
Young, J; (...); Calleja, JL
Article. 10.1186/s12879-016-2106-x. 2017
The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients
Roman A; (...); Ussetti P
Article. 10.1016/j.trre.2014.01.001. 2014
The Long-HER Study: Clinical and Molecular Analysis of Patients with HER2+Advanced Breast Cancer Who Become Long-Term Survivors with Trastuzumab-Based Therapy
Gamez-Pozo, Angelo; (...); Zamora, Pilar
Article. 10.1371/journal.pone.0109611. 2014
The morphology and primary lesion of the bicuspid aortic valve determines the aortic disease pattern
Hernandez, CE; (...); Montero, JA
Article. 10.1016/j.circv.2011.11.002. 2015
The Potential Role of Efficacy and Safety Evaluation of N-Acetylcysteine Administration During Liver Procurement. The NAC-400 Single Center Randomized Controlled Trial
Gomez-Gavara, C; (...); Lopez-Andujar, R
Article. 10.1097/TP.0000000000003487. 2021
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO).
Pizarro, David; (...); Palacios, Jose
Article. 10.3390/ijms241311183. 2023
The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis
Rodriguez-Tajes, Sergio; (...); Forns, Xavier
Article. 10.1111/liv.15777. 2024
The use of multisite left ventricular pacing via quadripolar lead improves acute haemodynamics and mechanical dyssynchrony assessed by radial strain speckle tracking: initial results
Osca J; (...); Salvador A
Article. 10.1093/europace/euv211. 2016
The use of prophylactic strategies using hepatitis B immunoglobulin for hepatitis B recurrence after liver transplantation in routine clinical practice in Spain. Preliminary results of the 1st round of a delphi panel
Prieto, M; (...); Casado, MA
Meeting Abstract. 10.1016/S0168-8278(17)30671-2. 2017
The Vascular Niche for Adult Cardiac Progenitor Cells.
Herrero, Diego; (...); Bernad, Antonio
Article. 10.3390/antiox11050882. 2022
Topical Administration of a Marine Oil Rich in Pro-Resolving Lipid Mediators Accelerates Wound Healing in Diabetic db/db Mice through Angiogenesis and Macrophage Polarization.
Ontoria-Oviedo, Imelda; (...); Sepulveda, Pilar
Article. 10.3390/ijms23179918. 2022
TRAIL-producing NK cells contribute to liver injury and related fibrogenesis in the context of GNMT deficiency
Fernández-Álvarez S; (...); Beraza N
Article. 10.1038/labinvest.2014.151. 2015
Trans-arterial chemoembolization with doxorubicin-eluting particles versus conventional trans-arterial chemoembolization in unresectable hepatocellular carcinoma: A study of effectiveness, safety and costs.
Megías Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.rx.2015.01.008. 2015
Translation of a tissue epigenetic signature to circulating free DNA suggests BCAT1 as a potential noninvasive diagnostic biomarker for lung cancer
Palanca-Ballester, Cora; (...); Sandoval, Juan
Article. 10.1186/s13148-022-01334-3. 2022
Transplantation of hESC-derived hepatocytes protects mice from liver injury
Tolosa L; (...); Dubart-Kupperschmitt A
Article. 10.1186/s13287-015-0227-6. 2015
Treatment of Hepatic Embryonal Undifferentiated Sarcoma With Cardiothoracic Involvement.
Domínguez-Massa C; (...); Montero-Argudo JA
Article. 10.1177/2150135118775411. 2020
Treatment of Hepatitis C Virus Infection in Patients With Cirrhosis and Predictive Value of Model for End-Stage Liver Disease: Analysis of Data From the Hepa-C Registry
Fernández Carrillo C; (...); Calleja, JL
Article. 10.1002/hep.29097. 2017
Triple Therapy for HCV Cirrhosis in Liver Transplant Candidates. High Rate of Prevention of HCV Recurrence after Liver Transplantation (LT) in Well Selected Patients
Maria Braithwaite, Ana; (...); Berenguer, Marina
Article. 2014
Tumor Microenvironment-Derived Metabolites: A Guide to Find New Metabolic Therapeutic Targets and Biomarkers
Review. 10.3390/cancers13133230. 2021
TWEAK and NT-proBNP levels predict exercise capacity in hypertrophic cardiomyopathy
Hernández-Romero D; (...); Marín F
Article. 10.1111/eci.12394. 2015
Two-component Peptidic Molecular Gels for Topical Drug Delivery of Naproxen
Martí-Centelles, Rosa; (...); Escuder, Beatriu
Article. 10.1021/acsabm.0c01422. 2021
Ultra-performance liquid chromatography-mass spectrometry targeted profiling of bile acids: application to serum, liver tissue, and cultured cells of different species.
García-Cañaveras JC, Donato MT, Lahoz A
Article. 10.1007/978-1-4939-1258-2_15. 2014
Universal access to direct-acting antivirals treatment is not not enough to prevent late stage presentation of hepatitis C infection
Cabezas, J; (...); Crespo, J
Meeting Abstract. 10.1016/S0618-8278(19)30970-3. 2019
Upgrading HepG2 cells with adenoviral vectors that encode drug-metabolizing enzymes: application for drug hepatotoxicity testing
Gomez-Lechon, MJ, Tolosa, L, Donato, MT
Review. 10.1080/17425255.2017.1238459. 2017
Urea-based recirculation validation of the symmetrical palindrome catheter.
Jonczyk, M; (...); de Bucourt, M
Article. 10.1111/jorc.12210. 2017
Use of a "CNI holidays" strategy in acute renal dysfunction late after heart transplant. Report of two cases.
Article. 2014
Use of an electrospun bioveil is safe and does not decrease skin graft take on burn wounds: A randomised, controlled clinical trial.
Perez-Del-Caz, Maria Dolores; (...); Perez-Plaza, Aranzazu
Article. 10.1016/j.burns.2025.107427. 2025
Use of artificial intelligence as an innovative donor-recipient matching model for liver transplantation: Results from a multicenter Spanish study
Briceño J; (...); de la Mata M
Article. 10.1016/j.jhep.2014.05.039. 2014
Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury
Robles-Diaz M; (...); Safer and Faster Evidence-based Translation Consortium
Article. 10.1053/j.gastro.2014.03.050. 2014
Use of liquid biomarker thymidine kinase activity (TKa) to predict outcome and progression in patients with metastatic breast cancer (MBC) in the GEICAM/2014-12 FLIPPER trial
Albanell, Joan; (...); Rojo Todo, Federico Gustavo
Meeting Abstract. https://doi.org/10.1200/JCO.2024.42.16_suppl.1028. 2024
Using high-content screening technology for studying drug-induced hepatotoxicity in preclinical studies
Donato, MT, Gomez-Lechon, MJ, Tolosa, L
Review. 10.1080/17460441.2017.1271784. 2017
Using Metabolomics to Uncover Ontogeny of Drug-Induced Hepatotoxicity and Underlying AOP Mechanisms
Martinez-Sena, T.; (...); Castell Ripoll, J. V.
Meeting Abstract. 2023
VI consensus document by the Spanish Liver Transplantation Society
Pardo, F; (...); Briceno, J
Article. 10.1016/j.ciresp.2017.12.013. 2018
VI consensus document by the Spanish Liver Transplantation Society
Pardo, F; (...); Briceno, J
Article. 10.1016/j.gastrohep.2018.05.012. 2018
Xenobiotic metabolism in differentiated human bronchial epithelial cells
Boei JJWA; (...); Vrieling, H
Article. 10.1007/s00204-016-1868-7. 2017
Method for predicting cardiotoxicity risk in cancer patients receiving anthracyclines chemotherapy (MIRCATOX)
Pilar Sepúlveda Sanchis;David Hervás Marín;Ana Santaballa Bertrán;Carmen Salvador Coloma;Ruben Carrero Garcia;Rafael Sánchez Sánchez;Akaitz Dorronsoro González;Imelda Ontoria Oviedo;Sandra Tejedor Gascón;Esteban Peiró Molina;Amparo Hernándiz Martínez;Hernán González King Garibotti;María Ciria Calduch;Delia Castellano Izquierdo;Joaquin Javier Panadero Romero;José Anastasio Montero Argudo;Nahuel Aquiles Garcia;Florian Caiment(U. Maastritch)5;Jort Merken_U. Maastritch;Jos Kleinjans_U. Maastritch;St
Patente - Patente europea. Fecha de Concesión: -
Method for predicting cardiotoxicity risk in cancer patients receiving anthracyclines chemotherapy (MIRCATOX)
Pilar Sepúlveda Sanchis;David Hervás Marín;Ana Santaballa Bertrán;Carmen Salvador Coloma;Ruben Carrero Garcia;Rafael Sánchez Sánchez;Akaitz Dorronsoro González;Imelda Ontoria Oviedo;Sandra Tejedor Gascón;Esteban Peiró Molina;Amparo Hernándiz Martínez;Hernán González King Garibotti;María Ciria Calduch;Delia Castellano Izquierdo;Joaquin Javier Panadero Romero;José Anastasio Montero Argudo;Nahuel Aquiles Garcia;Florian Caiment(U. Maastritch)5;Jort Merken_U. Maastritch;Jos Kleinjans_U. Maastritch;St
Patente - PCT. Fecha de Concesión: -
Method for predicting cardiotoxicity risk in cancer patients receiving anthracyclines chemotherapy (MIRCATOX)
Ruben Carrero Garcia;Rafael Sánchez Sánchez;Akaitz Dorronsoro González;Esteban Peiró Molina;Ana Santaballa Bertrán;Carmen Salvador Coloma;Imelda Ontoria Oviedo;Sandra Tejedor Gascón;Amparo Hernándiz Martínez;Hernán González King Garibotti;María Ciria Calduch;Delia Castellano Izquierdo;José Anastasio Montero Argudo;Pilar Sepúlveda Sanchis;David Hervás Marín;Nahuel Aquiles Garcia;Joaquin Javier Panadero Romero;Florian Caiment_U. Maastritch;Jort Merken_U. Maastritch;Jos Kleinjans_U. Maastritch;Step
Patente - Patente europea. Fecha de Concesión: -
Method for predicting cardiotoxicity risk in cancer patients receiving anthracyclines chemotherapy (MIRCATOX)
Ruben Carrero Garcia;Rafael Sánchez Sánchez;Akaitz Dorronsoro González;Esteban Peiró Molina;Ana Santaballa Bertrán;Carmen Salvador Coloma;Imelda Ontoria Oviedo;Sandra Tejedor Gascón;Amparo Hernándiz Martínez;Hernán González King Garibotti;María Ciria Calduch;Delia Castellano Izquierdo;José Anastasio Montero Argudo;Pilar Sepúlveda Sanchis;David Hervás Marín;Nahuel Aquiles Garcia;Joaquin Javier Panadero Romero;Florian Caiment(U. Maastritch)5;Jort Merken_U. Maastritch;Jos Kleinjans_U. Maastritch;St
Patente - Patente nacional. Fecha de Concesión: 22/10/2024